Advantage Investment Management’s Anavex Life Sciences AVXL Stock Holding History

Advantage Investment Management’s Portfolio AVXL Stock Details AVXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$9K	Hold	3,000	–	–	0.01%	659
2019 Q2	$10K	Hold	3,000	–	–	0.01%	653
2019 Q1	$9K	Hold	3,000	–	–	0.01%	660
2018 Q4	$5K	Hold	3,000	–	–	﹤0.01%	782
2018 Q3	$8K	Hold	3,000	–	–	0.01%	744
2018 Q2	$8K	Hold	3,000	–	–	0.01%	677
2018 Q1	$8K	Hold	3,000	–	–	﹤0.01%	705
2017 Q4	$10K	Buy	3,000 +2,000	+200%	+$7.87K	﹤0.01%	679
2017 Q3	$4K	Hold	1,000	–	–	﹤0.01%	841
2017 Q2	$5K	Hold	1,000	–	–	﹤0.01%	825
2017 Q1	$6K	Hold	1,000	–	–	﹤0.01%	771
2016 Q4	$4K	Buy	1,000 +500	+100%	+$1.78K	﹤0.01%	767
2016 Q3	$2K	Buy	+500	New	+$2.1K	﹤0.01%	816

Other funds holding AVXL

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Hikari Power Tokyo, Japan $1.15B AUM 5.31% 1-Year Est. Return

SMFS

Squar Milner Financial Services Irvine, California $176M AUM 10.56% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Advantage Investment Management's AVXL Position: Q3 2019 in Review

Advantage Investment Management held its Anavex Life Sciences (AVXL) position steady in Q3 2019 at 3,000 shares worth $9K. The position accounts for 0.01% of the portfolio, ranked #659.

Advantage Investment Management first reported a position in AVXL in Q3 2016 and has held it in 13 quarters since. The position peaked at $10K in Q2 2019. 61 funds tracked by Wall St. Rank hold AVXL as of Q3 2019.

Advantage Investment Management held 3,000 shares of Anavex Life Sciences worth $9K as of Q3 2019.
Advantage Investment Management left its Anavex Life Sciences share count unchanged in Q3 2019.
Anavex Life Sciences made up 0.01% of Advantage Investment Management's portfolio in Q3 2019, its #659 holding.
Advantage Investment Management first reported a position in Anavex Life Sciences in Q3 2016 and has held it in 13 quarters since.
Advantage Investment Management's Anavex Life Sciences position peaked at $10K in Q2 2019.
61 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q3 2019.

Based on Advantage Investment Management's 13F filing for Q3 2019, filed 8 Oct 2019.